Johnson & Johnson (jnj)
JNJ Earnings
Earnings history, surprises, and analyst consensus for Johnson & Johnson are available to Professional subscribers.
Earnings calendar & analyst consensus is available in Vest Terminal for Professional and Enterprise subscribers.
Johnson & Johnson FAQ
What does Johnson & Johnson (JNJ) do?
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers produc…
What is JNJ's P/E ratio?
Johnson & Johnson has a trailing P/E of 29.85× based on publicly available market data.
Does JNJ pay a dividend?
Indicated dividend yield: 2.1%. Confirm ex-dates and payout history in Vest Terminal.
What sector is JNJ in?
Johnson & Johnson is classified in Healthcare (Drug Manufacturers - General) on NYQ.
What is JNJ's market capitalization?
Approximate market cap: $619.30B.
What are the main risks for JNJ?
Standard market, competitive, and execution risks apply; see the Risks section.
What are the strengths of JNJ?
Potential positives include revenue growth of 6.6% year-over-year, return on equity near 25.7% — efficient use of shareholder capital.
Where can I get analyst estimates for JNJ?
Consensus estimates, price targets, and detailed analyst data for Johnson & Johnson are available to Professional subscribers in Vest Terminal — not on this public summary page.